Summary
Celldex Therapeutics , Inc.
Founded in 1983
Description
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system
Strengths
- Celldex Therapeutics , Inc. has a strong market share in their industry
- Revenue growth is more steady than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Since Celldex Therapeutics , Inc. was founded, the company has experienced slower revenue growth than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Celldex Therapeutics , Inc.'s annual revenue
$4140000
Based on Kona Equity data
-
Revenue per employee
$31364
-
Variance of revenue growth
0.03
-
Annual revenue growth since founding
$100975
-
Revenue growth rate from first known quarter to current
-72.0%
Employee Count
132 employees
-
Employee growth rate from first known quarter to current
-33.9%
Executives
Christopher Turner
Vice President Clinical Science
c**@celldex.comAnthony Marucci
CEO
a**@celldex.comChip Catlin
Senior Vice President, Chief Financial Officer (CFO) & Secretary
c**@celldex.comJohn Anstedt
Senior Vice President And Chief Business Officer
j**@celldex.comSusan Hew
Director, Information Technology
s**@celldex.comEleni Jolon
Senior Staff Accountant
e**@celldex.comElizabeth Crowley
Senior Vice President and Chief Product Development Officer
e**@celldex.comAmy Munroe
Control Senior Director, Quality
a**@celldex.comRichard Wright
Senior Vice President and Chief Commercial Officer
r**@celldex.comTibor Keler
Executive Vice President & Scientific Chief & Officer
t**@celldex.comElsa Paradise
Senior Manager, Clinical Trial
e**@celldex.comKimberly Grillo
Senior Manager, Clinical Trial
k**@celldex.comCierra Terceiro-Ciavatta
1 Quality Control Analyst
c**@celldex.comRonald Pepin
Chief Business Officer
r**@celldex.comBrian Ellis
Validation Engineer IV
b**@celldex.comBrandon Vu
Assistant Controller
b**@celldex.comHanan Mohammed
Vice President Preclinical RD And Bioanalytics
h**@celldex.comFreddy Jimenez
Senior VP & General Counsel
f**@celldex.comAndrea Chase
Manager, Accounting
a**@celldex.comChristopher Hemond
Executive Director Process R D
c**@celldex.comYufang Lu
Immunology Vice President, Clinical Development
y**@celldex.comCherie Taglienti
Director Clinical Science
c**@celldex.comDaniel Globy
Managing Director, Clinical Information Systems
d**@celldex.comHenry Marsh
Vice President, Research
h**@celldex.comChandler Ruehrwein
Director, Human Resources
c**@celldex.comSam Martin
Senior VP & Chief Financial Officer
s**@celldex.comColleen Patterson
Scientist II
c**@celldex.comPamela Morani
Scientist and Supervisor
p**@celldex.comRafael Curiel
Vice President, Medical Affairs
r**@celldex.comNancy Hoffler
Associate Director, Data Management
n**@celldex.comWilliam Delaney
Vice President, Project Management
w**@celldex.comLynne Tatevosian
Controller
l**@celldex.comRichard Khazzaka
Operations & Supply Vice President, Manufacturing
r**@celldex.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G5 Variance of revenue growth is less than the industry average
Web Analysis
-
Rank
2.46 M
-
Page views per visitor
1.9
-
Daily time
2:21
-
Bounce Rate
50.0 %
Location
Unlock unlimited leads
Similar Companies
Allakos, Inc.
allakos.com- Founded in 2012
- Location: San Carlos, California
- Annual Revenue: $64.8M
- Employees: 192
- Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Mirati Therapeutics
mirati.com- Founded in 1995
- Location: San Diego, CA
- Annual Revenue: $27.2M
- Employees: 587
- Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing targeted oncology products. They are dedicated to transforming the treatment of cancer by targeting the genetic changes in tumor cells that cause uncontrolled...
Y-mAbs Therapeutics Inc
ymabs.com- Founded in 2017
- Location: New York City, NY
- Annual Revenue: $40.0M
- Employees: 148
Harbour BioMed
harbourbiomed.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $4.3M
- Employees: 396
- Harbour BioMed (HBM Holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological diseases.
Tanox , Inc.
tanox.com- Founded in 1986
- Location: Houston, TX
- Annual Revenue: $10.7M
- Employees: 40
- Tanox is a technology company that specializes in developing innovative software solutions for businesses. With a focus on cutting-edge technologies, Tanox offers a wide range of products and services to help companies streamline their operations, impr...
Key Information
- Name: Celldex Therapeutics , Inc.
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 28; 283
- NAICS: 32541; 325412
See similar companies
-
By City Hampton Small Biotechnology Company in Hampton Mid-size Biotechnology Company in Hampton Biotechnology in Hampton Small Biotechnology in Hampton Mid-size Biotechnology in Hampton
-
By State NJ Small companies in NJ Biotechnology in NJ Small Biotechnology in NJ Mid-size Biotechnology in NJ Small Biotechnology Company in NJ Mid-size Biotechnology Company in NJ
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 2 Founded in 1983 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 325412 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Celldex Therapeutics , Inc.'s headquarters are located at 53 Frontage Rd. Ste. 220 Hampton, NJ 08827.
Celldex Therapeutics , Inc.'s official website is celldex.com
Celldex Therapeutics , Inc.'s annual revenue is $4.1 M.
Celldex Therapeutics , Inc.'s SIC: 28; 283
Celldex Therapeutics , Inc.'s NAICS: 32541; 325412.
Celldex Therapeutics , Inc. has 132 employees
Celldex Therapeutics , Inc. is in the industry of Biotechnology.
